×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [overall survival os]
Home >
overall survival os
Newest Approach to Breast Cancer
899 views
Emerging Issues with Adaptation of Clinical Trial Design in Drug Development* H.M. James Hung Division of Biometrics I, Office of Biostatistics, OPaSS,
213 views
Biomarkers and Surrogate Endpoints in Drug Development Technical and Regulatory Considerations Biomarkers and Surrogate Endpoints in Drug Development Technical.
223 views
Surrogate Endpoints: A Regulatory View Greg Campbell, Ph.D. Director, Division of Biostatistics Center for Devices and Radiological Health Food and Drug.
215 views
CRITICAL APPRAISAL ON AN ARTICLE ABOUT PROGNOSIS post.
217 views
First results from the phase III ALTTO trial (BIG 02-06; NCCTG 063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone.
214 views
SUTENT® (sunitinib malate) Slide Kit
842 views
Maintenance Therapy In Multiple Myeloma
1.630 views
Late Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome
487 views
EpiCept Corporation (EPCT)
849 views
Should triple negative breast cancer (tnbc) subtype
508 views
Survadapt-Webinar_2014_SLIDES
33 views
Next >